These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29885802)

  • 41. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
    Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.
    Bertran K; Balzli C; Lee DH; Suarez DL; Kapczynski DR; Swayne DE
    Vaccine; 2017 Nov; 35(46):6336-6344. PubMed ID: 28554502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.
    Balzli CL; Bertran K; Lee DH; Killmaster L; Pritchard N; Linz P; Mebatsion T; Swayne DE
    Vaccine; 2018 Jan; 36(1):84-90. PubMed ID: 29180030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines].
    Donina SA; Petukhova GD; Koren'kov DA; Grigor'eva EP; Kuznetsova SA; Losev IV; Rudenko LG; Naĭkhin AN
    Vopr Virusol; 2013; 58(3):37-42. PubMed ID: 24006632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective efficacy of a prime-boost protocol using H5-DNA plasmid as prime and inactivated H5N2 vaccine as the booster against the Egyptian avian influenza challenge virus.
    Hussein HA; Ahmed BM; Aly SM; El-Deeb AH; El-Sanousi AA; Rohaim MA; Arafa AA; Gadalla MR
    Acta Virol; 2016; 60(3):307-15. PubMed ID: 27640441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant Lactobacillus plantarum expressing HA2 antigen elicits protective immunity against H9N2 avian influenza virus in chickens.
    Yang WT; Yang GL; Yang X; Shonyela SM; Zhao L; Jiang YL; Huang HB; Shi CW; Wang JZ; Wang G; Zhao JH; Wang CF
    Appl Microbiol Biotechnol; 2017 Dec; 101(23-24):8475-8484. PubMed ID: 29090342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets.
    Cheng X; Zengel JR; Suguitan AL; Xu Q; Wang W; Lin J; Jin H
    J Infect Dis; 2013 Aug; 208(4):594-602. PubMed ID: 23656978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
    Naguib MM; Grund C; Arafa AS; Abdelwhab EM; Beer M; Harder TC
    J Gen Virol; 2017 Jun; 98(6):1169-1173. PubMed ID: 28590242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
    Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
    Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
    Song H; Nieto GR; Perez DR
    J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
    Sylte MJ; Hubby B; Suarez DL
    Vaccine; 2007 May; 25(19):3763-72. PubMed ID: 17350145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
    Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
    Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The response of mute swans (Cygnus olor, Gm. 1789) to vaccination against avian influenza with an inactivated H5N2 vaccine.
    Dolka B; Żbikowski A; Dolka I; Szeleszczuk P
    Acta Vet Scand; 2016 Oct; 58(1):74. PubMed ID: 27770803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine.
    Lee JS; Kim HS; Seo SH
    Vaccine; 2008 Dec; 26(51):6569-76. PubMed ID: 18838096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reverse genetics based H5N2 vaccine provides clinical protection against H5N1, H5N8 and H9N2 avian influenza infection in chickens.
    Panickan S; Bhatia S; Bhat S; Bhandari N; Pateriya AK; Kalaiyarasu S; Sood R; Tripathi M
    Vaccine; 2022 Nov; 40(48):6998-7008. PubMed ID: 36374710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effective mosaic-based nanovaccines against avian influenza in poultry.
    Kingstad-Bakke BA; Chandrasekar SS; Phanse Y; Ross KA; Hatta M; Suresh M; Kawaoka Y; Osorio JE; Narasimhan B; Talaat AM
    Vaccine; 2019 Aug; 37(35):5051-5058. PubMed ID: 31300285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.
    Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X
    Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.
    Chirkova TV; Naykhin AN; Petukhova GD; Korenkov DA; Donina SA; Mironov AN; Rudenko LG
    Clin Vaccine Immunol; 2011 Oct; 18(10):1710-8. PubMed ID: 21813657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.